RenovoRx
RNXT
14 hedge funds and large institutions have $473K invested in RenovoRx in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
56% more funds holding
Funds holding: 9 → 14 (+5)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.99% more ownership
Funds ownership: 2.41% → 3.4% (+0.99%)
14% less capital invested
Capital invested by funds: $552K → $473K (-$78.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Charles Schwab
San Francisco,
California
|
+$88.6K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.6K |
| 3 |
State Street
Boston,
Massachusetts
|
+$33.9K |
| 4 |
BlackRock
New York
|
+$27.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$24.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11.7K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.64K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LBC
1
Lawrence B. Cohen
| $129K | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $99.4K | +$34.6K | +19,250 | +35% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $70.3K | +$24.6K | +13,659 | +32% |
|
|
4
Charles Schwab
San Francisco,
California
| $62K | +$88.6K | +49,232 | New |
|
|
5
State Street
Boston,
Massachusetts
| $23.8K | +$33.9K | +18,852 | New |
|
|
6
BlackRock
New York
| $20.4K | +$27.6K | +15,334 | New |
|
|
LFAS
7
Level Four Advisory Services
Dallas,
Texas
| $19.9K | – | – | – |
|
|
ACA
8
Affinity Capital Advisors
Berkeley,
California
| $17.7K | – | – | – |
|
|
GSC
9
Ground Swell Capital
Folly Beach,
South Carolina
| $14.5K | +$20.7K | +11,481 | New |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $13K | -$3.64K | -2,023 | -16% |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $2.94K | -$11.7K | -6,512 | -75% |
|
12
Morgan Stanley
New York
| $234 | – | – | – |
|
13
Wells Fargo
San Francisco,
California
| $81 | +$22 | +12 | +24% |
|
14
JP Morgan Chase
New York
| $11 | +$16 | +9 | New |
|
RNXT Hedge Fund Activity: Q3 2023 in Review
14 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q3 2023, worth a combined $473K — down 14% from $552K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new RNXT positions and 0 closed out — a net gain of 5 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Charles Schwab, opening a new position worth an estimated $88.6K. The largest seller was Tower Research Capital (TRC), cutting an estimated $11.7K.
- 14 institutional investors held RenovoRx (RNXT) as of Q3 2023, up from 9 in Q2 2023.
- Funds reported $473K of RenovoRx stock for Q3 2023, down 14% quarter-over-quarter.
- 5 funds opened new RenovoRx positions in Q3 2023 and 0 closed out, a net change of +5 holders.
- The largest RenovoRx buyer in Q3 2023 was Charles Schwab, an estimated $88.6K added.
- The largest RenovoRx seller in Q3 2023 was Tower Research Capital (TRC), an estimated $11.7K sold.
Based on aggregated 13F filings for Q3 2023.